Inventor · disambiguated record
Gyorgy Pal Snell
Also filed as: SNELL GYORGY · SNELL GYORGY PAL
15 granted patents·10 pending applications·150 citations·filing 2004–2024
93Inventor score
Files withVIR BIOTECHNOLOGY INC10TAKEDA PHARMACEUTICALS CO8TAKEDA SAN DIEGO INC4TAKEDA PHARMACEUTICAL2ELIAS KATHLEEN ANN1
Top patents by PatentIndex Score
25 records- 0198US8362211B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICAL·Filed 2011·Granted Jan 29, 2013·71 cites·12 claims
- 0295US9676869B2Conjugated anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Jun 13, 2017·12 cites·20 claims
- 0394US11168128B2Antibodies against SARS-CoV-2 and methods of using the sameVIR BIOTECHNOLOGY INC·Filed 2021·Granted Nov 9, 2021·12 cites·30 claims
- 0494US10494444B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Dec 3, 2019·8 cites·10 claims
- 0594US10336833B2Conjugated anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Jul 2, 2019·9 cites·30 claims
- 0693US2025171561A1Anti-cd38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 0792US8926969B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICAL·Filed 2012·Granted Jan 6, 2015·14 cites·17 claims
- 0891US11479599B2Antibodies against SARS-CoV-2 and methods of using the sameVIR BIOTECHNOLOGY INC·Filed 2021·Granted Oct 25, 2022·2 cites·30 claims
- 0990US9790285B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2014·Granted Oct 17, 2017·7 cites·24 claims
- 1090US9102744B2Conjugated anti-CD38 antibodiesELIAS KATHLEEN ANN·Filed 2011·Granted Aug 11, 2015·13 cites·17 claims
- 1185US12209138B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Jan 28, 2025·0 cites·17 claims
- 1278US11434304B2Anti-CD38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 6, 2022·0 cites·28 claims
- 1372US2020031951A1Conjugated anti-cd38 antibodiesTAKEDA PHARMACEUTICALS CO·Filed 2019·Application pending·0 cites
- 1471US7368269B1Crystallization of MAPK/ERK Kinase 2TAKEDA SAN DIEGO INC·Filed 2005·Granted May 6, 2008·1 cites·11 claims
- 1571US2023331821A1Antibodies against sars-cov-2 and methods of using the sameVIR BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 1669US7534592B1Crystallization of carboxyltransferase domain of Acetyl-CoEnzyme A Carboxylase 2 with a ligandTAKEDA SAN DIEGO INC·Filed 2006·Granted May 19, 2009·1 cites·7 claims
- 1756US7241868B1Crystallization of Glucocorticoid ReceptorTAKEDA SAN DIEGO INC·Filed 2004·Granted Jul 10, 2007·0 cites·9 claims
- 1856US2025296986A1Engineered polypeptidesVIR BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 1955US7556950B1Crystallization of the catalytic domain of human phosphodiesterase 4-D3 (PDE4-D3)TAKEDA SAN DIEGO INC·Filed 2004·Granted Jul 7, 2009·0 cites·9 claims
- 2053US2023242621A1Engineered hepatitis b virus neutralizing antibodies and uses thereofVIR BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 2152US2024317841A1Antibodies against influenza a virusesVIR BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 2251US2025263466A1Antibodies against sars-cov-2 and methods of using the sameVIR BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 2350US2024141021A1Anti-influenza antibodies and combinations thereofVIR BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 2450US2024092876A1Broadly neutralizing antibodies against influenza neuraminidaseVIR BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 2550US2024059757A1Antibodies against sars-cov-2 and methods of using the sameVIR BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gyorgy Pal Snell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →